These data strongly suggest that the suppression of CAF-induced IL-6 secretion or pharmacologic inhibition of the IL-6 receptor counteracts the effect of CAF-induced chemotherapeutic resistance in GC cells. This evidence concerns the gene IL6 and gastric cancer.